K

Kyowa Kirin

Global specialty pharma focused on antibodies

Translational Research Intern - Translational Research

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Internship · Summer 2027Princeton, NJ, USA$23 - $25 /hr

About the Job

Requirements

  • Be a rising junior or senior in college or university, majoring in Molecular Biology, Proteomics, Bioinformatics, Biostatistics, or a related biological science field.
  • Be available to work from May 25, 2027, to August 20, 2027.
  • Have a minimum GPA of 3.0.
  • Live within a commutable distance of Princeton, New Jersey, and work a hybrid schedule.
  • Be eligible to work in the United States on a permanent and ongoing basis without sponsorship.
  • Have a good understanding of advanced molecular biology techniques and applications, including next-generation sequencing and gene expression methods or tools.
  • Be proficient in Microsoft Office.
  • Have strong oral and written communication skills.

Responsibilities

  • Download and prepare datasets, and analyze omics and genetic screening data.
  • Use bioinformatics web tools and participate in developing genomics data analytics processes, including artificial intelligence and machine-learning-based predictive analytics.
  • Participate in vendor meetings and manage data transfer, quality control, and data reconciliation activities with vendors and contract research organizations.
  • Collaborate with colleagues in the United States and Japan.

Desired Qualifications

  • Have experience or interest in bioinformatics, genomics, multi-omics, cancer research, and artificial intelligence or machine-learning tools for predictive modeling.
  • Have prior industry experience.
  • Have experience with R, Python, SAS/JMP, and other preferred computational tools.

About the Company

Kyowa Kirin

Global specialty pharma focused on antibodies

1) What does this company do? Kyowa Kirin develops specialty pharmaceutical drugs with a focus on nephrology, oncology, and immunology, built on a foundation of fermentation technology and antibody science. 2) How does this company's product(s) work? It uses fermentation-derived biology and antibody-based approaches to create therapies that target kidney disease, cancer, and immune-related conditions, delivered as approved medicines after research, development, and clinical testing. 3) How is this company different from its competitors? It blends deep fermentation and microbiology expertise with antibody technology from its history, plus a global specialty-drug focus, resulting from a merger of Kyowa Hakko Kogyo and Kirin Pharma that combined fermentation know-how with pharmaceutical resources. 4) What is this company's goal? To develop and commercialize innovative treatments that address unmet medical needs in nephrology, oncology, and immunology on a global scale.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Tokyo, Japan
Founded
1885

Recently Posted Jobs

Explore more opportunities at Kyowa Kirin

See more jobs